SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is drawing attention after Oracle reaffirmed its commitment to the Project Jupiter fuel-cell contract, easing concerns that a force majeure notice signaled a cancellation. Traders welcomed the reassurance and bought the pullback, though some remain wary of project delays, permitting risks, and the stocks valuation.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts Copilot overhaul, adding an always-on Autopilot agent, coding tools and deeper Office integration, is driving attention alongside the stocks sharp rise. Traders are celebrating the AI push and breakout momentum, while skeptics question whether the features justify the rally and warn the shares look overbought.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Bank of Americas downgrade, citing a longer Nike turnaround and continued sales pressure, is driving discussion ahead of the companys earnings report. Traders are divided between expecting further downside and viewing the downgrade as a late call or buying opportunity, with many waiting for managements results and guidance for signs of progress.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais expanded cloud-services agreement with Anthropic to support AI computing workloads is driving attention, as traders view it as a major validation of the companys cloud strategy. The initial enthusiasm has been tempered by a sharp fade, with debate over substantial upfront capital spending, potential dilution from warrants, and the delay before revenue ramps.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Reports of possible U.S.-Iran talks advancing and a potential Strait of Hormuz reopening dominated SPY discussion, with traders connecting the headlines and oil moves to sharp intraday swings. Many questioned the reports as unconfirmed or recycled news, while others saw possible de-escalation as bullish; rising Treasury yields remained a countervailing concern.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Goldman Sachs return to a Buy rating, citing improving Amtagvi launch execution and margins, is a major focus as IOVA rallies toward a new high. Traders are broadly upbeat, though some question the analyst reversal and are watching for the promised revenue-guidance update and upcoming NSCLC data.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to its Phase 3 melanoma cancer-vaccine trial meeting its primary endpoint and anticipation of the full results at ESMO, with CEO comments about the broader oncology pipeline adding to interest. Traders are split between bullish momentum and short-squeeze talk and concerns that the gains price in uncertain results and future commercial potential.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Ciphers Barber Lake data-center lease extension, including a follow-on commitment from an AI lab, has lengthened the contracted term and substantially increased expected revenue. Traders largely view the deal as a positive for Ciphers AI-infrastructure pivot, while debating construction-cost and financing risks and expressing frustration that the shares fell despite the news.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Speculative reports of progress in U.S.-Iran talks and a possible Strait of Hormuz reopening are driving discussion, with traders linking lower oil prices and a QQQ rally to hopes of easing geopolitical pressure. The reports remain unconfirmed, and the community is divided between bullish dip-buyers and skeptics focused on elevated Treasury yields and the risk of renewed volatility.

ERock, Inc. operates, designs, and installs distributed generation power systems. The firm primarily serves data centers, utilities, commercial and industrial businesses. The company was founded on 2006 and is headquartered in Houston, TX.

ERock Inc. - Ordinary Shares - Class A

ERocks Anthropic power-system order and Meta-linked data-center project have put its role in supplying on-site natural-gas power for AI infrastructure at the center of discussion, alongside a sharply expanded order backlog. Many traders are bullish on the growth opportunity and tight-float/short-interest setup, while skeptics point to post-IPO volatility, execution and profitability risks, and concerns about management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYDY FDA’s response to Bernie Sander’s inquiry is so typical.  

Bernie: Hey FDA, is shady shit going on with not giving leronlimab an EUA? 

FDA: Well, we keep stringing it along so its application is pending and trials are ongoing; therefore, we we’re not going to explain ourselves or comment on it.  

The precedent of not having to provide an explanation or discuss what’s happening here is very convenient for those trying to disadvantage companies not in the BP club.

MarcS

UseToBe4RingsPatsRule

Gary Edson, Ph.D.

STEVE SMITH

Wittymuk

Michael Steinmann

koon fah wong

Matt Brehl

Michael Lynn Baker

StockTwits for iOS

CytoDyn Inc

 FDA’s response to Bernie Sander’s inquiry is so typical.  

Bernie: Hey FDA, is shady shit going on with not giving leronlimab an EUA? 

FDA: Well, we keep stringing it along so its application is pending and trials are ongoing; therefore, we we’re not going to explain ourselves or comment on it.  

The precedent of not having to provide an explanation or discuss what’s happening here is very convenient for those trying to disadvantage companies not in the BP club.

Stan

Jo Pile

@bostalatl FDA letter translation:  Thanks for your letter Bernie, BP doesn’t want this drug approved so please stay in your lane and butt the fuck out and thank you for your service and support.  Love Janet ❤️

 FDA letter translation:  Thanks for your letter Bernie, BP doesn’t want this drug approved so please stay in your lane and butt the fuck out and thank you for your service and support.  Love Janet ❤️